2-anthramine has been researched along with Glioblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breakefield, XO; Chiocca, EA; Dobberstein, KU; Herrlinger, U; Hilton, J; Kramm, CM; Philpot, RM; Rainov, NG; Sena-Esteves, M | 1 |
1 other study(ies) available for 2-anthramine and Glioblastoma
Article | Year |
---|---|
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Brain Neoplasms; Culture Media, Conditioned; Cytochrome P-450 Enzyme System; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Genetic Therapy; Glioblastoma; Gliosarcoma; Glutathione; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Plasmids; Prodrugs; Rabbits; Rats; Terpenes; Transfection; Tumor Cells, Cultured | 1998 |